Senate panel sounds alarm about NIH funding in White House budget proposal

In The Headlines: Private funding can’t replace federal funding—but it can help

In the absence of the federal funding, cancer research will be leaning on private funders. But few private funders have the freedom to ask fundamental questions—questions whose answers may not have an immediate clinical impact but can dramatically advance scientific knowledge.

April 09, 2025

Vol.51 No.13

Amid HHS upheaval, Bhattacharya takes the helm at NIH, Makary at FDA
Meanwhile, NASEM sounds “SOS” for health infrastructure

The day before health economist Jay Bhattacharya stepped into his new role as NIH director, he sent a document to his employees outlining his top five priorities for the department, which included “reproducibility” and “transparency,” two themes he discussed at his confirmation hearings (The Cancer Letter, March 7, 2025).

April 04, 2025

Vol.51 No.13

By Claire Marie Porter, Paul Goldberg and Jacquelyn Cobb

Clinical Roundup

Fatty acids promote immune suppression and therapy resistance in triple negative breast cancer, Baylor Medicine study finds

A study published in the journal Immunity reveals a mechanism that allows triple negative breast cancer to develop resistance to therapy. Researchers at Baylor College of Medicine showed that lipid accumulation in tumor cells and nearby immune cells promotes immune suppression, but disrupting lipid formulation reverses treatment resistance and the immunosuppressive microenvironment.

April 04, 2025

Vol.51 No.13

Podcast

In The Headlines: HHS shakeup threatens a legacy of medical breakthroughs

“For the last 50 years every major medical breakthrough can be traced back to investments in the NIH, which houses the National Cancer Institute (NCI),” said Wayne A. I. Frederick, interim chief executive officer of American Cancer Society and the American Cancer Society Cancer Action Network.

April 02, 2025

Vol.51 No.12

In Brief

Cancer Research Institute commits $2.5M to fund postdoc fellowships

The Cancer Research Institute is committing $2.5 million in reserve funding to support an additional postdoctoral fellowships in the face of federal instability.

March 28, 2025

Vol.51 No.12

Clinical Roundup

Even light daily physical activity linked to lower cancer risk, NIH and Oxford study shows

In a prospective cohort study of more than 85,000 adults in the UK, researchers at the NIH and University of Oxford found that individuals who engaged in light- and moderate-to-vigorous-intensity daily physical activity had a lower risk of cancer than individuals who were more sedentary.

March 28, 2025

Vol.51 No.12

Senate panel sounds alarm about NIH funding in White House budget proposal

YOU MAY BE INTERESTED IN

In The Headlines: Private funding can’t replace federal funding—but it can help

Amid HHS upheaval, Bhattacharya takes the helm at NIH, Makary at FDA
Meanwhile, NASEM sounds “SOS” for health infrastructure

Fatty acids promote immune suppression and therapy resistance in triple negative breast cancer, Baylor Medicine study finds

In The Headlines: HHS shakeup threatens a legacy of medical breakthroughs

Cancer Research Institute commits $2.5M to fund postdoc fellowships

Even light daily physical activity linked to lower cancer risk, NIH and Oxford study shows

Renew today!

Subscriber content

Senate panel sounds alarm about NIH funding in White House budget proposal

YOU MAY BE INTERESTED IN

In The Headlines: Private funding can’t replace federal funding—but it can help

Amid HHS upheaval, Bhattacharya takes the helm at NIH, Makary at FDAMeanwhile, NASEM sounds “SOS” for health infrastructure

Fatty acids promote immune suppression and therapy resistance in triple negative breast cancer, Baylor Medicine study finds

In The Headlines: HHS shakeup threatens a legacy of medical breakthroughs

Cancer Research Institute commits $2.5M to fund postdoc fellowships

Even light daily physical activity linked to lower cancer risk, NIH and Oxford study shows

Amid HHS upheaval, Bhattacharya takes the helm at NIH, Makary at FDA
Meanwhile, NASEM sounds “SOS” for health infrastructure